Completed
Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg
NCT01073904
- Conditions
- Contraceptives, Postcoital
- Locations
-
- Morelia, Michoacán, Mexico